Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AC0FA0902140351517
Magnésium Glycinat (Bisglycinate)+B6, 1422 mg, 180 Capsules- Made in UK
midtail
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
38
▲ 90.0% vs prev 4w
Year-over-year
—
not enough history (need 56+ weeks)
Current stock
2
≈ 0.2 weeks of cover
Unit price
MAD 276
avg of last 30 sells · latest 2026-05-06
AC0FA0902140351517
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-06-08 · Total forecast: 247 units.
Actual
Forecast p50 (expected)
Forecast p95 (upper bound)
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnésium Glycinat (Bisglycinate)+B6, 1422 mg, 180 Capsules- Made in UK · in the midtail cohort · last 4 weeks 38 units, trending up +90.0% · on-hand 2 units
Signals the model saw
- Cohort: midtail (112 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.50 — moderate
- Recent trend: last 4w = 38 units · prev 4w = 20 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic (p50) — next week | 5.5 units |
| Realistic (p50) — next 4 weeks | 25.8 units |
| Realistic (p50) — next 3 months | 79.7 units |
| Optimistic (p95) — next week | 15.3 units |
| Optimistic (p95) — next 4 weeks (reorder target) | 73.8 units |
| Optimistic (p95) — next 3 months (quarterly PO target) | 247.1 units |
| Legacy μ/wk (reorder pipeline) | 6.1 |
| Revenue exposure — optimistic, 3 months | MAD 68.2K |